Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of
the current management of chronic obstructive pulmonary disease (COPD) and are critical in …

The development of therapeutic approaches to treat lung disease requires an understanding
of both the normal and disease physiology of the lung. Although traditional experimental …

Abstract The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma
guidelines for the diagnosis and management of asthma for adults and children, which is …

With the rapid growth of the nanotechnology industry, the need to understand the biological
effects of aerosol exposure has become increasingly important. Featuring contributions by …

Despite the passionate debate over the use of β2‐adrenoceptor agonists in the treatment of
airway disorders, these agents are still central in the symptomatic management of asthma …

Engineered porous phospholipid microparticles with aerodynamic diameters in the
respirable range of 1–2 μm were cosuspended in 1, 1, 1, 2-tetrafluoroethane, a propellant …

This is an updated guideline for the diagnosis and management of asthma, developed by
the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The …

This is the fourth version of the updated guidelines for the diagnosis and management of
asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi …

This an updated guidelines for the diagnosis and management of asthma, developed by the
Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The …

A novel series of potent and selective sulfonamide derived β2-adrenoreceptor agonists are
described that exhibit potential as inhaled ultra-long-acting bronchodilators for the treatment …